SCHEMBL8482527

SCHEMBL8482527

CCCn1cnc2c1c(=O)n(CCCCC(C)(O)C#CCNC(CC)CC)c(=O)n2C

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 9/20 0.56
▸ LMNA P02545 2/20 0.56
▸ CYP1A2 P05177 2/20 0.56
▸ NFKB1 P19838 2/20 0.56
▸ ACHE P22303 2/20 0.56
▸ PMP22 Q01453 2/20 0.56
▸ ESR1 P03372 1/20 0.56
▸ MAPT P10636 1/20 0.56
▸ BLM P54132 1/20 0.56
▸ PDE4B Q07343 8/20 0.44
▸ PDE4C Q08493 8/20 0.44
▸ PDE4D Q08499 8/20 0.44
▸ ADORA2A P29274 3/20 0.44
▸ ADORA2B P29275 3/20 0.44
▸ TNF P01375 2/20 0.40
▸ USP2 O75604 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8480836 0.89 PDE4A (0.57) PDE4ALMNACYP1A2NFKB1ACHE
SCHEMBL8485066 0.87 PDE4A (0.59) PDE4ALMNACYP1A2NFKB1ACHE
Hydrochloric Acid SCHEMBL8483879 0.86 PDE4A (0.58) PDE4ALMNACYP1A2NFKB1ACHE
SCHEMBL8480538 0.85 PDE4A (0.57) PDE4ALMNACYP1A2NFKB1ACHE
Hydrochloric Acid SCHEMBL8480119 0.85 PDE4A (0.56) PDE4ALMNACYP1A2NFKB1ACHE
SCHEMBL8479457 0.85 PDE4A (0.56) PDE4ALMNACYP1A2NFKB1ACHE
Hydrochloric Acid SCHEMBL8484711 0.84 PDE4A (0.56) PDE4ALMNACYP1A2NFKB1ACHE
SCHEMBL7803084 0.84 PDE4A (0.56) PDE4ALMNACYP1A2NFKB1ACHE
SCHEMBL8482531 0.84 PDE4A (0.56) PDE4ALMNACYP1A2NFKB1ACHE
SCHEMBL8481609 0.83 PDE4A (0.55) PDE4ALMNACYP1A2NFKB1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5965555-A TREATMENT AND/OR PROPHYLAXIS OF CEREBROVASCULAR DISORDERS CHARACTERIZED BY DAMAGE CAUSED BY ISCHEMIA AND SUBSEQUENT NECROTIC DESTRUCTION OF NERVE CELLS(NEURONS) HOECHST AKTIENGESELLSCHAFT (DE) 1999-10-12 — — US disclosed
Send feedback